company background image
UTMD

Utah Medical ProductsNasdaqGS:UTMD Stock Report

Market Cap

US$338.0m

7D

5.8%

1Y

21.7%

Updated

23 Sep, 2021

Data

Company Financials
UTMD fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

UTMD Overview

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry.

Utah Medical Products Competitors

Merit Medical Systems

NasdaqGS:MMSI

US$4.1b

STERIS

NYSE:STE

US$21.5b

Mesa Laboratories

NasdaqGS:MLAB

US$1.6b

LeMaitre Vascular

NasdaqGM:LMAT

US$1.2b

Price History & Performance

Summary of all time highs, changes and price drops for Utah Medical Products
Historical stock prices
Current Share PriceUS$95.17
52 Week HighUS$78.13
52 Week LowUS$95.65
Beta0.24
1 Month Change8.73%
3 Month Change9.39%
1 Year Change21.67%
3 Year Change1.24%
5 Year Change57.41%
Change since IPO1,327.55%

Recent News & Updates

Aug 06
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

The board of Utah Medical Products, Inc. ( NASDAQ:UTMD ) has announced that it will pay a dividend on the 5th of...

Shareholder Returns

UTMDUS Medical EquipmentUS Market
7D5.8%-1.0%-1.7%
1Y21.7%37.7%36.2%

Return vs Industry: UTMD underperformed the US Medical Equipment industry which returned 37.7% over the past year.

Return vs Market: UTMD underperformed the US Market which returned 36.2% over the past year.

Price Volatility

Is UTMD's price volatile compared to industry and market?
UTMD volatility
UTMD Beta0.24
Industry Beta0.88
Market Beta1

Stable Share Price: UTMD is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: UTMD's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1978181Kevin Cornwellhttps://www.utahmed.com

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies.

Utah Medical Products Fundamentals Summary

How do Utah Medical Products's earnings and revenue compare to its market cap?
UTMD fundamental statistics
Market CapUS$338.04m
Earnings (TTM)US$12.80m
Revenue (TTM)US$46.06m

27.1x

P/E Ratio

7.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
UTMD income statement (TTM)
RevenueUS$46.06m
Cost of RevenueUS$17.56m
Gross ProfitUS$28.49m
ExpensesUS$15.70m
EarningsUS$12.80m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)3.51
Gross Margin61.87%
Net Profit Margin27.78%
Debt/Equity Ratio0%

How did UTMD perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

32%

Payout Ratio

Valuation

Is Utah Medical Products undervalued compared to its fair value and its price relative to the market?

24.9%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: UTMD ($95.17) is trading below our estimate of fair value ($126.64)

Significantly Below Fair Value: UTMD is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: UTMD is good value based on its PE Ratio (27.1x) compared to the US Medical Equipment industry average (51.1x).

PE vs Market: UTMD is poor value based on its PE Ratio (27.1x) compared to the US market (17.7x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate UTMD's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: UTMD is good value based on its PB Ratio (3.2x) compared to the US Medical Equipment industry average (4.7x).


Future Growth

How is Utah Medical Products forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

15.3%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Utah Medical Products has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Utah Medical Products performed over the past 5 years?

1.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: UTMD has high quality earnings.

Growing Profit Margin: UTMD's current net profit margins (27.8%) are lower than last year (28.4%).


Past Earnings Growth Analysis

Earnings Trend: UTMD's earnings have grown by 1.1% per year over the past 5 years.

Accelerating Growth: UTMD's earnings growth over the past year (2.2%) exceeds its 5-year average (1.1% per year).

Earnings vs Industry: UTMD earnings growth over the past year (2.2%) underperformed the Medical Equipment industry 40.5%.


Return on Equity

High ROE: UTMD's Return on Equity (11.9%) is considered low.


Financial Health

How is Utah Medical Products's financial position?


Financial Position Analysis

Short Term Liabilities: UTMD's short term assets ($70.6M) exceed its short term liabilities ($4.4M).

Long Term Liabilities: UTMD's short term assets ($70.6M) exceed its long term liabilities ($5.0M).


Debt to Equity History and Analysis

Debt Level: UTMD is debt free.

Reducing Debt: UTMD had no debt 5 years ago.

Debt Coverage: UTMD has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: UTMD has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Utah Medical Products's current dividend yield, its reliability and sustainability?

1.20%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: UTMD's dividend (1.2%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.35%).

High Dividend: UTMD's dividend (1.2%) is low compared to the top 25% of dividend payers in the US market (3.63%).


Stability and Growth of Payments

Stable Dividend: UTMD's dividends per share have been stable in the past 10 years.

Growing Dividend: UTMD's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (32.2%), UTMD's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

24.2yrs

Average board tenure


CEO

Kevin Cornwell (74 yo)

28.75yrs

Tenure

US$327,340

Compensation

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...


CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD327.34K) is below average for companies of similar size in the US market ($USD1.69M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: UTMD's board of directors are seasoned and experienced ( 24.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: UTMD insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Utah Medical Products, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Utah Medical Products, Inc.
  • Ticker: UTMD
  • Exchange: NasdaqGS
  • Founded: 1978
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$338.041m
  • Shares outstanding: 3.65m
  • Website: https://www.utahmed.com

Number of Employees


Location

  • Utah Medical Products, Inc.
  • 7043 South 300 West
  • Midvale
  • Utah
  • 84047-1048
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/09/23 22:56
End of Day Share Price2021/09/23 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.